公司資料
Syros Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- SYRS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (+300.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, SYRS closed up 300.0% at $0.0004. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Syros sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, target validation, and the ability to create a durable oncology story.
生技產業定位
Syros is a small-cap oncology catalyst name whose valuation depends on early data and strategic progress.
未來催化劑
- Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。